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and NTD90, rep.). NTD parameter was evaluated in a virtual structure 
consisting of an adjacent tissue shell surrounding the target volume by 
adding a 1 cm margin. A two tailed Student t-test (α= 0.05) was 
performed for comparison of each parameter. 
Results: Small differences were found between the two MLCs for the 
average values of the dosimetric parameters analysed: CISTD= 1.45 vs 
CIHD= 1.41 (p= 0.119); GSTD=5.8 mm vs GHD= 5.6 mm (p< 0.0002) ; 
V12STD=5.77 cc vs V12HD= 5.49 cc (p< 0.02); NTD50STD= 43.41 cc vs 
NTD50HD= 41.16 cc (p< 0.01); NTD70STD= 22.62 cc vs NTD50HD = 21.19 
cc (p<0.002); and NTD90STD= 9.52 cc vs NTD90HD= 8.84 cc (p< 0.02).  
Conclusions: While the 2.5 mm HD MLC gives slightly better values 
than the 5 mm MLC for all parameters analysed, the differences seem 
clinically not relevant.  
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Purpose/Objective: The use of 16-bit depth scanner images (CT) for 
dose calculation in radiotherapy allows considering the density of 
high-Z material, while12-bit depth CT saturates. The aim of this study 
is to evaluate the dosimetric impact of metallic implants considering 
12 and 16-bit CT images, for helical treatments. Pelvic, Head and 
Neck and prostheses irradiations are considered. 
Materials and Methods: Dosimetric calculations were performed 
withTomoTherapy® planning software (voLOTM). Extended CT to 
physical density curve (CT-PD) was derived from tissue 
characterization phantom with Titanium insert (7200 ± 90 HU , 4.59 
g/cc). TomoTherapy® planning software extrapolates linearly the CT-
PD curve for HU numbers above the maximum point of the curve. Ten 
patients were considered for each of the 3 localizations. For each 
patient, an extended (16-bit) and non-extended (12-bit) version of the 
same CT were reconstructed. Artifacts in soft tissues due to metallic 
implants were manually corrected. Moreover, as reference, a metal-
free CT was created for each patient by replacing metallic densities 
with bone, teeth or soft tissue densities. For helical irradiation, all 
gantry angles were allowed. Number of Monitor Unit (MU), dose 
distribution andHistogram-Dose-Volume (HDV) were compared. 
Results: For 12-bit CT, metallic implants saturates at 3071 HU (2.68 
g/cc), while for 16-bit CT, range CT numbers were [7000-16500 
HU](i.e. [4.76 – 9.51 g/cc]) and [5000-31700 HU] (i.e. [3.76 – 17.11 
g/cc]) for hip prostheses and metallic dental filling, respectively. For 
Head and Neck and pelvic helical irradiations, no significant 
differences were observed for MU and dose distribution, between 
calculation from 16-bit, 12-bit and metal-free CT. For prostheses 
irradiation, MU calculation from 12-bit depth CT and metal-free CT 
are similar, while calculation from 16-bit depth CT increased MU 
calculation more than 5%. 
Conclusions: Real physical densities of metallic implants such as 
prosthese sand dental filling are much higher than maximal density of 
12-bit depth CT images. However, for helical treatment, due to the 
important number of projections, metallic implants such as prostheses 
and dental filling have a negligible impact on dose calculation for non-
metallic targets. Therefore, avoiding metallic structures is not 
necessary allowing a better target-dose conformity and organ-at-risk 
sparing. On the contrary, for metallic irradiation, the use of non-
saturated images increases significantly MU calculation (>5%). 
However, the extrapolation of CT-PD curve and accuracy of algorithms 
in high densities medium should be investigated. Modification in 
practice for metallic targets should be considered carefully. 
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Purpose/Objective: In 2008 Papiez and Timmerman have written: 
'The main obstacle for safe application of the SBRT (...) is the 
unavailability of data that allow unambiguous determination of the 
parameters for fractionation schemes and dose prescriptions.' Plan 
comparison is difficult with various prescriptions (80% of maximum 
dose, on the 70% or 50%), a large variety of indexes are used 
(conformity, gradient …). Furthermore in clinical studies, only one 
dose is reported most of the times which does not permit to precisely 
describe the dose distribution. In 2010 the report of AAPM TG 101 
suggests to report SBRT with 'prescription ICRU reference point or 
dose/volume e.g., isodose covering PTV to a particular 
percentage,(…), plan conformity (…), heterogeneity index (…)'. At the 
same time ICRU report 83 for IMRT was published, because of inherent 
heterogeneities of IMRT plans the ICRU point is abandoned and 
prescription is based on median target dose. Can we conciliate these 2 
reports? 
Materials and Methods: Theoretical plans with Cyberknife, in 
anthropomorphic phantom, for spherical GTV of 2, 3, 4 and 5 mm with 
a PTV margin of 1 mm were created with prescription of 10 Gy on 
74%, 65%, 54% and 47% of maximum dose respectively, perfectly 
adjusted to cover 95% of PTV. GTV median doses were collected. 
Plans with a shift equal to the PTV margin, in the direction of the 
minimum observed in the dose distribution, were created and the GTV 
median doses were again collected. The same exercise was made with 
GTV of 21, 23, 25, 27 mm and a PTV margin of 2 mm. And again with 
GTV of 57, 59, 61, 63 mm and a PTV margin of 3 mm. 3 different 
clinical situations: brain metastases, prostate and lung lesion were 
assessed with different percentage of maximum dose used for 
prescription and again applying a shift. 
Results: The GTV median dose is little sensitive to the minimum in the 
PTV, and thus remains almost constant with the shift of the isocenter 
in all cases i.e. when we imagine a systematic error equal to the PTV 
margin. With the 6 mm PTV and a prescription isodose of 54%, i.e. 
with a fall-off of 20%/mm at the edge of the PTV, the GTV median 
dose is 14.77 Gy and 14.75 Gy with the shift. For the particular case 
of lung where the PTV includes a low density region, using Monte-
Carlo calculation, the GTV median dose is also stable with the shift. In 
case of a steep dose gradient, even with heterogeneity, the GTV 
median dose is stable when the GTV moves within the PTV. Using the 
GTV median dose we have a good description of the actually dose 
delivered.  
Theoretical plans with a PTV margin of 2 mm  
PTV diameter (mm)  31 29 27 25 
GTV diameter (mm)  27 25 23 21 
prescription isodose in % of max
PTV D95% = 10 Gy  49% 59% 71% 81% 
GTV median dose (Gy)  17,9 15,4 13,2 11,7 
GTV median dose (Gy) with a shift  17,9 15,4 13,3 11,7 
differences  0,0% 0,0% 0,1% 0,0% 
  
Conclusions: The GTV D50% appears to be a convenient way to 
describe the dose distributions, whatever the % of maximum dose 
used for prescription, and may help for treatment comparison in 
SBRT. For a better understanding of the dose distributions, every 
team should report PTV D98%, PTV D95%, PTV D2% and GTV median 
dose like ICRU report 83 recommends for IMRT, in order to compare 
clinical studies. 
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